Literature DB >> 17558461

Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.

C Kenney1, J Jankovic.   

Abstract

Blepharospasm and hemifacial spasm are the two most common craniofacial movement disorders. Blepharospasm is a syndrome characterized by excessive or continuous eye closure related to overactivity of the orbicularis oculi and adjacent muscles bilaterally. Hemifacial spasm is a peripherally-induced movement disorder typically caused by vascular compression of cranial nerve VII (CN VII) leading to involuntary unilateral contractions of muscles used in facial expression. Treatment options for both conditions include medications, botulinum toxin, and various surgical interventions. This article summarizes the existing medical literature which indicates that botulinum toxin is the treatment of choice for blepharospasm and hemifacial spasm.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17558461     DOI： 10.1007/s00702-007-0768-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  50 in total

Review 1.  Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm.

Authors:  W H Jost; A Kohl
Journal:  J Neurol       Date:  2001-04       Impact factor: 4.849

2.  Prevalence of primary blepharospasm in Sardinia, Italy: a service-based survey.

Authors:  Giovanni Cossu; Alessandra Mereu; Marcello Deriu; Maurizio Melis; Andrea Molari; Giannina Melis; Laura Minafra; Tiziana Pisano; Carlo Cianchetti; Enzo Ortu; Gianfranco Sau; Isidoro Aiello; Miriana Fresu; Maria Giovanna Marrosu; Paolo Contu
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

3.  A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm.

Authors:  Carlos R M Rieder; Pedro Schestatsky; Mariana Peixoto Socal; Thaís Lampert Monte; Daniele Fricke; João Costa; Paulo Dornelles Picon
Journal:  Clin Neuropharmacol       Date:  2007 Jan-Feb       Impact factor: 1.592

Review 4.  Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases.

Authors:  S Jitpimolmard; S Tiamkao; M Laopaiboon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

5.  Pretarsal injections of botulinum toxin improve blephospasm in previously unresponsive patients.

Authors:  L Kowal
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

6.  Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid force.

Authors:  H Iwashige; Y Nemeto; H Takahashi; T Maruo
Journal:  Jpn J Ophthalmol       Date:  1995       Impact factor: 2.447

7.  Health-related quality of life in blepharospasm or hemifacial spasm.

Authors:  J Reimer; K Gilg; A Karow; J Esser; G H Franke
Journal:  Acta Neurol Scand       Date:  2005-01       Impact factor: 3.209

8.  Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984.

Authors:  R G Auger; J P Whisnant
Journal:  Arch Neurol       Date:  1990-11

9.  Hemifacial spasm: clinical findings and treatment.

Authors:  A Wang; J Jankovic
Journal:  Muscle Nerve       Date:  1998-12       Impact factor: 3.217

10.  Treatment of tic douloureux and hemifacial spasm by posterior fossa exploration: therapeutic implications of various neurovascular relationships.

Authors:  J H Piatt; R H Wilkins
Journal:  Neurosurgery       Date:  1984-04       Impact factor: 4.654
View more
  24 in total

1.  Functional end-plate recovery in long-term botulinum toxin therapy of hemifacial spasm: a nerve conduction study.

Authors:  C Butera; R Guerriero; S Amadio; D Ungaro; H Tesfaghebriel; F Bianchi; G Comi; U Del Carro
Journal:  Neurol Sci       Date:  2012-02-25       Impact factor: 3.307

Review 2.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

3.  Hemifacial spasm: a neurosurgical perspective.

Authors:  Doo-Sik Kong; Kwan Park
Journal:  J Korean Neurosurg Soc       Date:  2007-11-20

4.  Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport.

Authors:  Katja Kollewe; Bahram Mohammadi; Reinhard Dengler; Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2010-05-01       Impact factor: 3.575

Review 5.  Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment.

Authors:  Bettina Wabbels; Peter Roggenkämper
Journal:  J Neural Transm (Vienna)       Date:  2012-01-10       Impact factor: 3.575

6.  Blepharospasm: long-term treatment with either Botox®, Xeomin® or Dysport®.

Authors:  Katja Kollewe; Bahram Mohammadi; Steffen Köhler; Heidrun Pickenbrock; Reinhard Dengler; Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2014-07-25       Impact factor: 3.575

7.  Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation.

Authors:  Phillip M Radke; Ali Mokhtarzadeh; Michael S Lee; Andrew R Harrison
Journal:  Neuroophthalmology       Date:  2017-07-18

8.  The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm.

Authors:  Marcello Esposito; A Fasano; C Crisci; R Dubbioso; R Iodice; Lucio Santoro
Journal:  Neurol Sci       Date:  2013-08-15       Impact factor: 3.307

9.  Surgical approach to limiting skin contracture following protractor myectomy for essential blepharospasm.

Authors:  Jeremy Clark; John Randolph; Jason A Sokol; Nicholas A Moore; Hui Bae H Lee; William R Nunery
Journal:  Digit J Ophthalmol       Date:  2017-11-05

10.  Double-blind, randomized, comparative study of Meditoxin versus Botox in the treatment of essential blepharospasm.

Authors:  Jin Sook Yoon; Jae Chan Kim; Sang Yeul Lee
Journal:  Korean J Ophthalmol       Date:  2009-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.